The global brain cancer diagnostics market is expected to grow from US$ 1,639.10 million in 2022 to US$ 7,378.57 million by 2028.
The increase in brain cancer worldwide and the rise in cigarette smokers boost the growth of the global brain cancer diagnostics market.
The term"primary brain tumor" refers to a tumor that begins in the brain. Cancer of the brain and nervous system is the tenth highest cause of mortality in men and women. According to the American Society of Clinical Oncology (ASCO), in 2021, around 24,530 adults (13,840 men and 10,690 women) were diagnosed with primary cancerous tumors of the brain and spinal cord in the US. In a person's lifetime, the chances of having this form of tumor are fewer than 1%. Most primary central nervous system (CNS) malignancies are brain tumors, which account for 85% to 90% of all cases. Brain tumors can be fatal, severely impact the quality of life, and ultimately transform a patient's and their family's lives.
Similarly, Cancer Research UK estimated that around 12,288 new cases of brain, other CNS, and intracranial tumors are diagnosed in the UK each year, which makes it around 34 cases per day (2016-2018). Brain tumors, other central nervous systems, and intracranial tumors are the ninth most common malignancies in the UK, accounting for 3% of all new cancer cases (2016-2018). Also, it is the 7th most common cancer in females in the UK, with around 6,400 new cases during 2016-2018. Similarly, in males, brain, other CNS, and intracranial tumors are the 11th most common cancer, with about 5,800 new cases in the UK during 2016-2018. Incidence rates for brain tumors are highest in people aged 85 to 89 (2016-2018) in the UK.
According to the American Association of Neurological Surgeons, glioblastoma is the most common malignant brain and other CNS tumor, accounting for 47.7% of all cases; the incidence of glioblastoma is 3.21 per 100,000 people. According to Cancer Australia, around 1,879 new cases of brain cancer were diagnosed in Australia in 2020.
Early detection of tumors often provides more treatment options. Advanced imaging technology can pinpoint the location of brain tumors. Intraoperative MRI can also be used to guide tissue biopsy and tumor resection during surgery. Magnetic resonance spectroscopy (MRS) is used to examine the chemical characteristics of tumors. Thus, the increase in the prevalence of brain cancer worldwide highly demands brain cancer diagnostic tools.
The COVID-19 pandemic diverted resources from healthcare services for patients with diseases such as cancer. The brain cancer diagnostics market witnessed some shortfall at the beginning of the COVID-19 crisis owing to factors such as disruption in the supply chain and demand due to the lack of lockdown announced by most countries. Patients with cancer were negatively impacted during the COVID-19 pandemic, as many of these individuals were immunosuppressed and of older age. Additionally, cancer follow-up or imaging appointments were delayed in many clinics worldwide. Postponement of routine screening examinations resulted in delays in new cancer diagnoses. A delay in cancer diagnosis due to the COVID-19 pandemic resulted in an increase in cancer-related mortality. Studies on COVID-19 in patients with cancer were limited but consistently indicate that this population is at risk for more severe COVID-19 illness. Recent studies also suggest that pediatric patients with cancer have a lower risk of severe COVID-19 illness than adults. Thus, the pandemic had a negative impact on the growth of the brain cancer diagnostics market.
Based on diagnostics type, the brain cancer diagnostics market is segmented into imaging test, lumbar puncture, biopsy, molecular testing, platform & services, cerebral arteriogram, neurological & hearing tests/neurocognitive assessments, electroencephalography (EEG), and others. Molecular testing segment further sub-segmented into MRI, CT scan, PET, and others. Platform & services segment is further sub-segmented into sample slide, autosampler unit, solutions and platform, and services. In 2022, the imaging test segment is expected to have the largest market share. Moreover, the platform and services market for this segment is estimated to grow at the fastest CAGR during the forecast period.
Based on cancer type, the brain cancer diagnostics market is segmented into acoustic neuroma, astrocytomas, craniopharyngiomas, ganglioneuromas, glioblastoma multiforme, ganglioneuroma, meningiomas, ependymomas, oligodendroglioma, low-grade tumors, and others. In 2022, the glioblastoma multiforme segment is estimated to hold the largest market share. The same segment is expected to register the highest CAGR from 2022 to 2028.
Based on tumor size, the brain cancer diagnostics market is segmented into 0.2 cm3 to 100 cm3, 101 cm3 to 200 cm3, and above 200 cm3. In 2022, the 0.2 cm3 to 100 cm3 segment is estimated to hold the largest share of the market. The same segment is expected to register the highest CAGR from 2022 to 2028.
Based on end user, the brain cancer diagnostics market is segmented into hospitals, specialty clinics, ambulatory surgical centers, diagnostic centers & research institutes, and others. In 2022, the hospitals segment is expected to account for the largest share of the market. Moreover, the specialty clinics segment is expected to register the highest CAGR from 2022 to 2028.
American Society of Clinical Oncology (ASCO), American Association of Neurological Surgeons, Centers for Disease Control and Prevention (CDC), World Health Organization, National Library of Medicine, The American Cancer Society, Japan Radiology Society, Globocan 2020 are among the primary and secondary sources referred to while preparing the report on the brain cancer diagnostics market.
The increase in brain cancer worldwide and the rise in cigarette smokers boost the growth of the global brain cancer diagnostics market.
The term"primary brain tumor" refers to a tumor that begins in the brain. Cancer of the brain and nervous system is the tenth highest cause of mortality in men and women. According to the American Society of Clinical Oncology (ASCO), in 2021, around 24,530 adults (13,840 men and 10,690 women) were diagnosed with primary cancerous tumors of the brain and spinal cord in the US. In a person's lifetime, the chances of having this form of tumor are fewer than 1%. Most primary central nervous system (CNS) malignancies are brain tumors, which account for 85% to 90% of all cases. Brain tumors can be fatal, severely impact the quality of life, and ultimately transform a patient's and their family's lives.
Similarly, Cancer Research UK estimated that around 12,288 new cases of brain, other CNS, and intracranial tumors are diagnosed in the UK each year, which makes it around 34 cases per day (2016-2018). Brain tumors, other central nervous systems, and intracranial tumors are the ninth most common malignancies in the UK, accounting for 3% of all new cancer cases (2016-2018). Also, it is the 7th most common cancer in females in the UK, with around 6,400 new cases during 2016-2018. Similarly, in males, brain, other CNS, and intracranial tumors are the 11th most common cancer, with about 5,800 new cases in the UK during 2016-2018. Incidence rates for brain tumors are highest in people aged 85 to 89 (2016-2018) in the UK.
According to the American Association of Neurological Surgeons, glioblastoma is the most common malignant brain and other CNS tumor, accounting for 47.7% of all cases; the incidence of glioblastoma is 3.21 per 100,000 people. According to Cancer Australia, around 1,879 new cases of brain cancer were diagnosed in Australia in 2020.
Early detection of tumors often provides more treatment options. Advanced imaging technology can pinpoint the location of brain tumors. Intraoperative MRI can also be used to guide tissue biopsy and tumor resection during surgery. Magnetic resonance spectroscopy (MRS) is used to examine the chemical characteristics of tumors. Thus, the increase in the prevalence of brain cancer worldwide highly demands brain cancer diagnostic tools.
The COVID-19 pandemic diverted resources from healthcare services for patients with diseases such as cancer. The brain cancer diagnostics market witnessed some shortfall at the beginning of the COVID-19 crisis owing to factors such as disruption in the supply chain and demand due to the lack of lockdown announced by most countries. Patients with cancer were negatively impacted during the COVID-19 pandemic, as many of these individuals were immunosuppressed and of older age. Additionally, cancer follow-up or imaging appointments were delayed in many clinics worldwide. Postponement of routine screening examinations resulted in delays in new cancer diagnoses. A delay in cancer diagnosis due to the COVID-19 pandemic resulted in an increase in cancer-related mortality. Studies on COVID-19 in patients with cancer were limited but consistently indicate that this population is at risk for more severe COVID-19 illness. Recent studies also suggest that pediatric patients with cancer have a lower risk of severe COVID-19 illness than adults. Thus, the pandemic had a negative impact on the growth of the brain cancer diagnostics market.
Based on diagnostics type, the brain cancer diagnostics market is segmented into imaging test, lumbar puncture, biopsy, molecular testing, platform & services, cerebral arteriogram, neurological & hearing tests/neurocognitive assessments, electroencephalography (EEG), and others. Molecular testing segment further sub-segmented into MRI, CT scan, PET, and others. Platform & services segment is further sub-segmented into sample slide, autosampler unit, solutions and platform, and services. In 2022, the imaging test segment is expected to have the largest market share. Moreover, the platform and services market for this segment is estimated to grow at the fastest CAGR during the forecast period.
Based on cancer type, the brain cancer diagnostics market is segmented into acoustic neuroma, astrocytomas, craniopharyngiomas, ganglioneuromas, glioblastoma multiforme, ganglioneuroma, meningiomas, ependymomas, oligodendroglioma, low-grade tumors, and others. In 2022, the glioblastoma multiforme segment is estimated to hold the largest market share. The same segment is expected to register the highest CAGR from 2022 to 2028.
Based on tumor size, the brain cancer diagnostics market is segmented into 0.2 cm3 to 100 cm3, 101 cm3 to 200 cm3, and above 200 cm3. In 2022, the 0.2 cm3 to 100 cm3 segment is estimated to hold the largest share of the market. The same segment is expected to register the highest CAGR from 2022 to 2028.
Based on end user, the brain cancer diagnostics market is segmented into hospitals, specialty clinics, ambulatory surgical centers, diagnostic centers & research institutes, and others. In 2022, the hospitals segment is expected to account for the largest share of the market. Moreover, the specialty clinics segment is expected to register the highest CAGR from 2022 to 2028.
American Society of Clinical Oncology (ASCO), American Association of Neurological Surgeons, Centers for Disease Control and Prevention (CDC), World Health Organization, National Library of Medicine, The American Cancer Society, Japan Radiology Society, Globocan 2020 are among the primary and secondary sources referred to while preparing the report on the brain cancer diagnostics market.
Table of Contents
1. Introduction1.1 Scope of the Study
1.2 Report Guidance
1.3 Market Segmentation
1.3.1 Global Brain Cancer Diagnostics Market - By Diagnostic Type
1.3.2 Global Brain Cancer Diagnostics Market - By Cancer Type
1.3. 3 Global Brain Cancer Diagnostics Market - By End User
1.3.4 Global Brain Cancer Diagnostics Market - By Tumor Size
1.3.5 Global Brain Cancer Diagnostics Market - By Geography
2. Brain Cancer Diagnostics Market - Key Takeaways
3. Research Methodology
3.1 Coverage
3.2 Secondary Research
3.3 Primary Research
4. Brain Cancer Diagnostics Market - Market Landscape
4.1 Overview
4.2 PEST Analysis
4.2.1 North America PEST Analysis
4.2.2 Europe PEST Analysis
4.2.3 Asia Pacific PEST Analysis
4.2.4 Middle East and Africa PEST Analysis
4.2.5 South and Central America PEST Analysis
4.3 Experts Opinion
5. Brain Cancer Diagnostics Market - Key Market Dynamics
5.1 Market Drivers
5.1.1 Increase in Brain Cancer Worldwide
5.1.2 Rise in Cigarette Smokers
5.2 Market Restraints
5.2.1 High Cost of Brain Tumor Diagnosis
5.3 Market Opportunities
5.3.1 Increasing R & amp;D for Developing Advance Technology
5.4 Future Trends
5.4.1 Advancement in Brain Tumor Diagnosis
5.5 Impact Analysis
6. Brain Cancer Diagnostics Market - Global Analysis
6.1 Global Brain Cancer Diagnostics Market Revenue Forecast And Analysis
6.1.1 Global Brain Cancer Diagnostics Market Revenue Forecast And Analysis
6.1.2 Global Brain Cancer Diagnostics Market - Market Potential Analysis, By Region
6.2 Market Positioning Analysis Of Key Players In Brain Cancer Diagnostics Market
6.2.1 Company Analysis
6.2.2 Growth Strategy Analysis
6.2.3 Performance Of Key Players
6.2.3.1 Koninklijke Philips N.V.
6.2.3.2 GE Healthcare
7. Global Brain Cancer Diagnostic Market Revenue and Forecasts To 2028 - by Diagnostic Type
7.1 Overview
7.2 Global Brain Cancer Diagnostic Market, By Diagnostic Type, 2021 & 2028 (%)
7.3 Imaging Test
7.3.1 Overview
7.3.2 Imaging Test: Brain Cancer Diagnostic Market Revenue and Forecasts to 2028 (US$ Million)
7.3.2.1 MRI
7.3.2.1.1 Overview
7.3.2.1.2 MRI: Brain Cancer Diagnostic Market Revenue and Forecast to 2028 (US$ Million)
7.3.2.2 CT Scan
7.3.2.2.1 Overview
7.3.2.2.2 CT Scan: Brain Cancer Diagnostic Market Revenue and Forecast to 2028 (US$ Million)
7.3.2.3 PET
7.3.2.3.1 Overview
7.3.2.3.2 PET: Brain Cancer Diagnostic Market Revenue and Forecast to 2028 (US$ Million)
7.3.2.4 Others
7.3.2.4.1 Overview
7.3.2.4.2 Others: Brain Cancer Diagnostic Market Revenue and Forecast to 2028 (US$ Million)
7.4 Molecular Testing
7.4.1 Overview
7.4.2 Molecular Testing: Brain Cancer Diagnostic Market Revenue and Forecasts to 2028 (US$ Million)
7.5 Lumbar Puncture
7.5.1 Overview
7.5.2 Lumbar Puncture: Brain Cancer Diagnostic Market Revenue and Forecasts to 2028 (US$ Million)
7.6 Electroencephalography (EEG)
7.6.1 Overview
7.6.2 Electroencephalography (EEG): Brain Cancer Diagnostic Market Revenue and Forecasts to 2028 (US$ Million)
7.7 Platform and Services
7.7.1 Overview
7.7.2 Platform and Services: Brain Cancer Diagnostic Market Revenue and Forecasts to 2028 (US$ Million)
7.7.2.1 Sample Slide
7.7.2.1.1 Overview
7.7.2.1.2 Sample Slide: Brain Cancer Diagnostic Market Revenue and Forecast to 2028 (US$ Million)
7.7.2.2 Autosampler Unit
7.7.2.2.1 Overview
7.7.2.2.2 Autosampler Unit: Brain Cancer Diagnostic Market Revenue and Forecast to 2028 (US$ Million)
7.7.2.3 Solutions and Platform
7.7.2.3.1 Overview
7.7.2.3.2 Solutions and Platform: Brain Cancer Diagnostic Market Revenue and Forecast to 2028 (US$ Million)
7.7.2.4 Services
7.7.2.4.1 Overview
7.7.2.4.2 Services: Brain Cancer Diagnostic Market Revenue and Forecast to 2028 (US$ Million)
7.8 Cerebral arteriogram
7.8.1 Overview
7.8.2 Cerebral arteriogram: Brain Cancer Diagnostic Market Revenue and Forecasts to 2028 (US$ Million)
7.9 Neurological and hearing tests/Neurocognitive Assessments
7.9.1 Overview
7.9.2 Neurological and hearing tests/Neurocognitive Assessments: Brain Cancer Diagnostic Market Revenue and Forecasts to 2028 (US$ Million)
7.10 Others
7.10.1 Overview
7.10.2 Others: Brain Cancer Diagnostic Market Revenue and Forecasts to 2028 (US$ Million)
8. Brain Cancer Diagnostic Market Revenue and Forecasts To 2028 - Cancer Type
8.1 Overview
8.2 Global Brain Cancer Diagnostic Market Share by Cancer Type - 2021 & 2028 (%)
8.3 Glioblastoma Multiforme
8.3.1 Overview
8.3.2 Glioblastoma Multiforme: Brain Cancer Diagnostic Market Revenue and Forecast to 2028 (US$ Million)
8.4 Astrocytomas
8.4.1 Overview
8.4.2 Astrocytomas: Brain Cancer Diagnostic Market Revenue and Forecast to 2028 (US$ Million)
8.5 Ependymomas
8.5.1 Overview
8.5.2 Ependymomas: Brain Cancer Diagnostic Market Revenue and Forecast to 2028 (US$ Million)
8.6 Meningiomas
8.6.1 Overview
8.6.2 Meningiomas: Brain Cancer Diagnostic Market Revenue and Forecast to 2028 (US$ Million)
8.7 Low-Grade Tumors
8.7.1 Overview
8.7.2 Low-Grade Tumors: Brain Cancer Diagnostic Market Revenue and Forecast to 2028 (US$ Million)
8.8 Oligodendroglioma
8.8.1 Overview
8.8.2 Oligodendroglioma: Brain Cancer Diagnostic Market Revenue and Forecast to 2028 (US$ Million)
8.9 Acoustic Neuroma
8.9.1 Overview
8.9.2 Acoustic Neuroma: Brain Cancer Diagnostic Market Revenue and Forecast to 2028 (US$ Million)
8.10 Craniopharyngiomas
8.10.1 Overview
8.10.2 Craniopharyngiomas: Brain Cancer Diagnostic Market Revenue and Forecast to 2028 (US$ Million)
8.11 Ganglioneuromas
8.11.1 Overview
8.11.2 Ganglioneuromas: Brain Cancer Diagnostic Market Revenue and Forecast to 2028 (US$ Million)
8.12 Others
8.12.1 Overview
8.12.2 Others: Brain Cancer Diagnostic Market Revenue and Forecast to 2028 (US$ Million)
9. Brain Cancer Diagnostic Market Revenue and Forecasts To 2028 - Tumor Size
9.1 Overview
9.2 Global Brain Cancer Diagnostic Market Share by Tumor Size - 2021 & 2028 (%)
9.3 0.2 cm3 to 100 cm3
9.3.1 Overview
9.3.2 0.2 cm3 to 100 cm3: Brain Cancer Diagnostic Market Revenue and Forecast to 2028 (US$ Million)
9.4 cm3 to 200 cm3
9.4.1 Overview
9.4.2 cm3 to 200 cm3: Brain Cancer Diagnostic Market Revenue and Forecast to 2028 (US$ Million)
9.5 Above 200 cm3
9.5.1 Overview
9.5.2 Above 200 cm3: Brain Cancer Diagnostic Market Revenue and Forecast to 2028 (US$ Million)
10. Brain Cancer Diagnostic Market Revenue and Forecasts To 2028 - End User
10.1 Overview
10.2 Global Brain Cancer Diagnostic Market Share by End User- 2021 & 2028 (%)
10.3 Hospitals
10.3.1 Overview
10.3.2 Hospitals: Brain Cancer Diagnostic Market Revenue and Forecast to 2028 (US$ Million)
10.4 Specialty Clinics
10.4.1 Overview
10.4.2 Specialty Clinics: Brain Cancer Diagnostic Market Revenue and Forecast to 2028 (US$ Million)
10.5 Diagnostic Centers and Research Institutes
10.5.1 Overview
10.5.2 Diagnostic Centers and Research Institutes: Brain Cancer Diagnostic Market Revenue and Forecast to 2028 (US$ Million)
10.6 Ambulatory Surgical Centers
10.6.1 Overview
10.6.2 Ambulatory Surgical Centers: Brain Cancer Diagnostic Market Revenue and Forecast to 2028 (US$ Million)
10.7 Others
10.7.1 Overview
10.7.2 Others: Brain Cancer Diagnostic Market Revenue and Forecast to 2028 (US$ Million)
11. Brain Cancer Diagnostics Market Revenue and Forecast to 2028 - by Geography
11.1 North America: Brain Cancer Diagnostics Market
11.1.1 Overview
11.1.2 North America Brain Cancer Diagnostics Market - Revenue and Forecast to 2028 (USD Million)
11.1.3 North America Brain Cancer Diagnostics Market, by Diagnostic Type - Revenue and Forecast to 2028 (USD Million)
11.1.3.1 North America Brain Cancer Diagnostics Market, by Imaging Test - Revenue and Forecast to 2028 (USD Million)
11.1.3.2 North America Brain Cancer Diagnostics Market, by Platform and Services - Revenue and Forecast to 2028 (USD Million)
11.1.4 North America Brain Cancer Diagnostics Market, by Cancer Type - Revenue and Forecast to 2028 (USD Million)
11.1.5 North America Brain Cancer Diagnostics Market, by End User - Revenue and Forecast to 2028 (USD Million)
11.1.6 North America Brain Cancer Diagnostics Market, by Tumor Size - Revenue and Forecast to 2028 (USD Million)
11.1.7 North America: Brain Cancer Diagnostics Market, by Country, 2022 & 2028 (%)
11.1.7.1 US: Brain Cancer Diagnostics Market - Revenue and Forecast to 2028 (USD Million)
11.1.7.1.1 Overview
11.1.7.1.2 US: Brain Cancer Diagnostics Market - Revenue and Forecast to 2028 (USD Million)
11.1.7.1.3 US Brain Cancer Diagnostics Market, by Diagnostic Type - Revenue and Forecast to 2028 (USD Million)
11.1.7.1.3.1 US Brain Cancer Diagnostics Market, by Imaging Test - Revenue and Forecast to 2028 (USD Million)
11.1.7.1.3.2 US Brain Cancer Diagnostics Market, by Platform and Services - Revenue and Forecast to 2028 (USD Million)
11.1.7.1.4 US Brain Cancer Diagnostics Market, by Cancer Type - Revenue and Forecast to 2028 (USD Million)
11.1.7.1.5 US Brain Cancer Diagnostics Market, by End User - Revenue and Forecast to 2028 (USD Million)
11.1.7.1.6 US Brain Cancer Diagnostics Market, by Tumor Size - Revenue and Forecast to 2028 (USD Million)
11.1.7.2 Canada: Brain Cancer Diagnostics Market - Revenue and Forecast to 2028 (USD Million)
11.1.7.2.1 Overview
11.1.7.2.2 Canada: Brain Cancer Diagnostics Market - Revenue and Forecast to 2028 (USD Million)
11.1.7.2.3 Canada Brain Cancer Diagnostics Market, by Diagnostic Type - Revenue and Forecast to 2028 (USD Million)
11.1.7.2.3.1 Canada Brain Cancer Diagnostics Market, by Imaging Test - Revenue and Forecast to 2028 (USD Million)
11.1.7.2.3.2 Canada Brain Cancer Diagnostics Market, by Platform and Services - Revenue and Forecast to 2028 (USD Million)
11.1.7.2.4 Canada Brain Cancer Diagnostics Market, by Cancer Type - Revenue and Forecast to 2028 (USD Million)
11.1.7.2.5 Canada Brain Cancer Diagnostics Market, by End User - Revenue and Forecast to 2028 (USD Million)
11.1.7.2.6 Canada Brain Cancer Diagnostics Market, by Tumor Size - Revenue and Forecast to 2028 (USD Million)
11.1.7.3 Mexico: Brain Cancer Diagnostics Market - Revenue and Forecast to 2028 (USD Million)
11.1.7.3.1 Overview
11.1.7.3.2 Mexico: Brain Cancer Diagnostics Market - Revenue and Forecast to 2028 (USD Million)
11.1.7.3.3 Mexico Brain Cancer Diagnostics Market, by Diagnostic Type - Revenue and Forecast to 2028 (USD Million)
11.1.7.3.3.1 Mexico Brain Cancer Diagnostics Market, by Imaging Test - Revenue and Forecast to 2028 (USD Million)
11.1.7.3.3.2 Mexico Brain Cancer Diagnostics Market, by Platform and Services - Revenue and Forecast to 2028 (USD Million)
11.1.7.3.4 Mexico Brain Cancer Diagnostics Market, by Cancer Type - Revenue and Forecast to 2028 (USD Million)
11.1.7.3.5 Mexico Brain Cancer Diagnostics Market, by End User - Revenue and Forecast to 2028 (USD Million)
11.1.7.3.6 Mexico Brain Cancer Diagnostics Market, by Tumor Size - Revenue and Forecast to 2028 (USD Million)
11.2 Europe: Brain Cancer Diagnostics Market
11.2.1 Overview
11.2.2 Europe: Brain Cancer Diagnostics Market Revenue and Forecasts to 2028 (US$ Mn)
11.2.3 Europe Brain Cancer Diagnostics Market Revenue and Forecasts to 2028, By Diagnostic Type (US$ Mn)
11.2.3.1 Europe Brain Cancer Diagnostics Market Revenue and Forecasts to 2028, by Imaging Test (US$ Mn)
11.2.3.2 Europe Brain Cancer Diagnostics Market Revenue and Forecasts to 2028, By Platform and Services (US$ Mn)
11.2.4 Europe Brain Cancer Diagnostics Market Revenue and Forecasts to 2028, by Cancer Type (US$ Mn)
11.2.5 Europe Brain Cancer Diagnostics Market Revenue and Forecasts to 2028, by End User (US$ Mn)
11.2.6 Europe Brain Cancer Diagnostics Market Revenue and Forecasts to 2028, by Tumor Size (US$ Mn)
11.2.7 Europe Brain Cancer Diagnostics Market Revenue and Forecasts to 2028, By Country (%)
11.2.7.1 UK Brain Cancer Diagnostics Market Revenue and Forecasts to 2028 (US$ Mn)
11.2.7.1.1 Overview
11.2.7.1.2 UK Brain Cancer Diagnostics Market Revenue and Forecasts to 2028 (US$ Mn)
11.2.7.1.3 UK Brain Cancer Diagnostics Market Revenue and Forecasts to 2028, By Diagnostic Type (US$ Mn)
11.2.7.1.3.1 UK Brain Cancer Diagnostics Market Revenue and Forecasts to 2028, By Imaging Test (US$ Mn)
11.2.7.1.3.2 UK Brain Cancer Diagnostics Market Revenue and Forecasts to 2028, By Platform and Services (US$ Mn)
11.2.7.1.4 UK Brain Cancer Diagnostics Market Revenue and Forecasts to 2028, by Cancer Type (US$ Mn)
11.2.7.1.5 UK Brain Cancer Diagnostics Market Revenue and Forecasts to 2028, by End User (US$ Mn)
11.2.7.1.6 UK Brain Cancer Diagnostics Market Revenue and Forecasts to 2028, by Tumor Size (US$ Mn)
11.2.7.2 Germany Brain Cancer Diagnostics Market Revenue and Forecasts to 2028 (US$ Mn)
11.2.7.2.1 Overview
11.2.7.2.2 Germany Brain Cancer Diagnostics Market Revenue and Forecasts to 2028 (US$ Mn)
11.2.7.2.3 Germany Brain Cancer Diagnostics Market Revenue and Forecasts to 2028, By Diagnostic Type (US$ Mn)
11.2.7.2.3.1 Germany Brain Cancer Diagnostics Market Revenue and Forecasts to 2028, By Imaging Test (US$ Mn)
11.2.7.2.3.2 Germany Brain Cancer Diagnostics Market Revenue and Forecasts to 2028, By Platform and Services (US$ Mn)
11.2.7.2.4 Germany Brain Cancer Diagnostics Market Revenue and Forecasts to 2028, by Cancer Type (US$ Mn)
11.2.7.2.5 Germany Brain Cancer Diagnostics Market Revenue and Forecasts to 2028, by End User (US$ Mn)
11.2.7.2.6 Germany Brain Cancer Diagnostics Market Revenue and Forecasts to 2028, by Tumor Size (US$ Mn)
11.2.7.3 France Brain Cancer Diagnostics Market Revenue and Forecasts to 2028 (US$ Mn)
11.2.7.3.1 Overview
11.2.7.3.2 France Brain Cancer Diagnostics Market Revenue and Forecasts to 2028 (US$ Mn)
11.2.7.3.3 France Brain Cancer Diagnostics Market Revenue and Forecasts to 2028, By Diagnostic Type (US$ Mn)
11.2.7.3.3.1 France Brain Cancer Diagnostics Market Revenue and Forecasts to 2028, By Imaging Test (US$ Mn)
11.2.7.3.3.2 France Brain Cancer Diagnostics Market Revenue and Forecasts to 2028, By Platform and Services (US$ Mn)
11.2.7.3.4 France Brain Cancer Diagnostics Market Revenue and Forecasts to 2028, by Cancer Type (US$ Mn)
11.2.7.3.5 France Brain Cancer Diagnostics Market Revenue and Forecasts to 2028, by End User (US$ Mn)
11.2.7.3.6 France Brain Cancer Diagnostics Market Revenue and Forecasts to 2028, by Tumor Size (US$ Mn)
11.2.7.4 Italy Brain Cancer Diagnostics Market Revenue and Forecasts to 2028 (US$ Mn)
11.2.7.4.1 Overview
11.2.7.4.2 Italy Brain Cancer Diagnostics Market Revenue and Forecasts to 2028 (US$ Mn)
11.2.7.4.3 Italy Brain Cancer Diagnostics Market Revenue and Forecasts to 2028, By Diagnostic Type (US$ Mn)
11.2.7.4.3.1 Italy Brain Cancer Diagnostics Market Revenue and Forecasts to 2028, By Imaging Test (US$ Mn)
11.2.7.4.3.2 Italy Brain Cancer Diagnostics Market Revenue and Forecasts to 2028, By Platform and Services (US$ Mn)
11.2.7.4.4 Italy Brain Cancer Diagnostics Market Revenue and Forecasts to 2028, by Cancer Type (US$ Mn)
11.2.7.4.5 Italy Brain Cancer Diagnostics Market Revenue and Forecasts to 2028, by End User (US$ Mn)
11.2.7.5 Italy Brain Cancer Diagnostics Market Revenue and Forecasts to 2028, by Tumor Size (US$ Mn)
11.2.7.6 Spain Brain Cancer Diagnostics Market Revenue and Forecasts to 2028 (US$ Mn)
11.2.7.6.1 Overview
11.2.7.6.2 Spain Brain Cancer Diagnostics Market Revenue and Forecasts to 2028 (US$ Mn)
11.2.7.6.3 Spain Brain Cancer Diagnostics Market Revenue and Forecasts to 2028, By Diagnostic Type (US$ Mn)
11.2.7.6.3.1 Spain Brain Cancer Diagnostics Market Revenue and Forecasts to 2028, By Imaging Test (US$ Mn)
11.2.7.6.3.2 Spain Brain Cancer Diagnostics Market Revenue and Forecasts to 2028, By Platform and Services (US$ Mn)
11.2.7.6.4 Spain Brain Cancer Diagnostics Market Revenue and Forecasts to 2028, by Cancer Type (US$ Mn)
11.2.7.6.5 Spain Brain Cancer Diagnostics Market Revenue and Forecasts to 2028, by End User (US$ Mn)
11.2.7.7 Rest of Europe Brain Cancer Diagnostics Market Revenue and Forecasts to 2028 (US$ Mn)
11.2.7.7.1 Overview
11.2.7.7.2 Rest of Europe Brain Cancer Diagnostics Market Revenue and Forecasts to 2028 (US$ Mn)
11.2.7.7.3 Rest of Europe Brain Cancer Diagnostics Market Revenue and Forecasts to 2028, By Diagnostic Type (US$ Mn)
11.2.7.7.3.1 Rest of Europe Brain Cancer Diagnostics Market Revenue and Forecasts to 2028, By Imaging Test (US$ Mn)
11.2.7.7.3.2 Rest of Europe Brain Cancer Diagnostics Market Revenue and Forecasts to 2028, By Platform and Services (US$ Mn)
11.2.7.7.4 Rest of Europe Brain Cancer Diagnostics Market Revenue and Forecasts to 2028, by Cancer Type (US$ Mn)
11.2.7.7.5 Rest of Europe Brain Cancer Diagnostics Market Revenue and Forecasts to 2028, by End User (US$ Mn)
11.2.7.7.6 Rest of Europe Brain Cancer Diagnostics Market Revenue and Forecasts to 2028, by Tumor Size (US$ Mn)
11.3 Asia Pacific Brain Cancer Diagnostics Market Revenue and Forecast To 2028
11.3.1 Overview
11.3.2 Asia Pacific Brain Cancer Diagnostic Market Revenue and Forecasts to 2028 (US$ Million)
11.3.3 Asia Pacific: Brain Cancer Diagnostic Market Revenue and Forecasts to 2028, By Diagnostic Type (US$ Million)
11.3.3.1 Asia Pacific: Brain Cancer Diagnostic Market, by Imaging Test, 2019 - 2028 (US$ Million)
11.3.3.2 Asia Pacific: Brain Cancer Diagnostic Market, by Platform and Services, 2019 - 2028 (US$ Million)
11.3.4 Asia Pacific: Brain Cancer Diagnostic Market Revenue and Forecasts to 2028, By Cancer Type (US$ Million)
11.3.5 Asia Pacific: Brain Cancer Diagnostic Market Revenue and Forecasts to 2028, By Tumor Size (US$ Million)
11.3.6 Asia Pacific: Brain Cancer Diagnostic Market Revenue and Forecasts to 2028, By End User (US$ Million)
11.3.7 Asia Pacific: Brain Cancer Diagnostic Market Revenue and Forecasts to 2028, By Country (%)
11.3.7.1 Japan: Brain Cancer Diagnostic Market Revenue and Forecasts to 2028 (US$ Million)
11.3.7.1.1 Overview
11.3.7.1.2 Japan: Brain Cancer Diagnostic Market Revenue and Forecasts to 2028 (US$ Million)
11.3.7.1.3 Japan: Brain Cancer Diagnostic Market Revenue and Forecasts to 2028, By Diagnostic Type (US$ Million)
11.3.7.1.3.1 Japan: Brain Cancer Diagnostic Market, by Imaging Test, 2019 - 2028 (US$ Million)
11.3.7.1.3.2 Japan: Brain Cancer Diagnostic Market, by Platform and Services, 2019 - 2028 (US$ Million)
11.3.7.1.4 Japan: Brain Cancer Diagnostic Market Revenue and Forecasts to 2028, By Cancer Type (US$ Million)
11.3.7.1.5 Japan: Brain Cancer Diagnostic Market, by Tumor Size - Revenue and Forecast to 2028 (US$ Million)
11.3.7.1.6 Japan: Brain Cancer Diagnostic Market, by End User - Revenue and Forecast to 2028 (US$ Million)
11.3.7.2 China: Brain Cancer Diagnostic Market Revenue and Forecasts to 2028 (US$ Million)
11.3.7.2.1 Overview
11.3.7.2.2 China: Brain Cancer Diagnostic Market Revenue and Forecasts to 2028 (US$ Million)
11.3.7.2.3 China: Brain Cancer Diagnostic Market Revenue and Forecasts to 2028, By Diagnostic Type (US$ Million)
11.3.7.2.3.1 China: Brain Cancer Diagnostic Market, by Imaging Test, 2019 - 2028 (US$ Million)
11.3.7.2.3.2 China: Brain Cancer Diagnostic Market, by Platform and Services, 2019 - 2028 (US$ Million)
11.3.7.2.4 China: Brain Cancer Diagnostic Market Revenue and Forecasts to 2028, By Cancer Type (US$ Million)
11.3.7.2.5 China: Brain Cancer Diagnostic Market, by Tumor Size - Revenue and Forecast to 2028 (US$ Million)
11.3.7.2.6 China: Brain Cancer Diagnostic Market, by End User - Revenue and Forecast to 2028 (US$ Million)
11.3.7.3 India Brain Cancer Diagnostic Market Revenue and Forecasts to 2028 (US$ Million)
11.3.7.3.1 Overview
11.3.7.3.2 India: Brain Cancer Diagnostic Market Revenue and Forecasts to 2028 (US$ Million)
11.3.7.3.3 India: Brain Cancer Diagnostic Market Revenue and Forecasts to 2028, By Diagnostic Type (US$ Million)
11.3.7.3.3.1 India: Brain Cancer Diagnostic Market, by Imaging Test, 2019 - 2028 (US$ Million)
11.3.7.3.3.2 India: Brain Cancer Diagnostic Market, by Platform and Services, 2019 - 2028 (US$ Million)
11.3.7.3.4 India: Brain Cancer Diagnostic Market Revenue and Forecasts to 2028, By Cancer Type (US$ Million)
11.3.7.3.5 India: Brain Cancer Diagnostic Market, by Tumor Size - Revenue and Forecast to 2028 (US$ Million)
11.3.7.3.6 India: Brain Cancer Diagnostic Market, by End User - Revenue and Forecast to 2028 (US$ Million)
11.3.7.4 South Korea: Brain Cancer Diagnostic Market Revenue and Forecasts to 2028 (US$ Million)
11.3.7.4.1 Overview
11.3.7.4.2 South Korea: Brain Cancer Diagnostic Market Revenue and Forecasts to 2028 (US$ Million)
11.3.7.4.3 South Korea: Brain Cancer Diagnostic Market Revenue and Forecasts to 2028, By Diagnostic Type (US$ Million)
11.3.7.4.3.1 South Korea: Brain Cancer Diagnostic Market, by Imaging Test, 2019 - 2028 (US$ Million)
11.3.7.4.3.2 South Korea: Brain Cancer Diagnostic Market, by Platform and Services, 2019 - 2028 (US$ Million)
11.3.7.4.4 South Korea: Brain Cancer Diagnostic Market Revenue and Forecasts to 2028, By Cancer Type (US$ Million)
11.3.7.4.5 South Korea: Brain Cancer Diagnostic Market, by Tumor Size - Revenue and Forecast to 2028 (US$ Million)
11.3.7.4.6 South Korea: Brain Cancer Diagnostic Market, by End User - Revenue and Forecast to 2028 (US$ Million)
11.3.7.5 Australia: Brain Cancer Diagnostic Market Revenue and Forecasts to 2028 (US$ Million)
11.3.7.5.1 Overview
11.3.7.5.2 Australia: Brain Cancer Diagnostic Market Revenue and Forecasts to 2028 (US$ Million)
11.3.7.5.3 Australia: Brain Cancer Diagnostic Market Revenue and Forecasts to 2028, By Diagnostic Type (US$ Million)
11.3.7.5.3.1 Australia: Brain Cancer Diagnostic Market, by Imaging Test, 2019 - 2028 (US$ Million)
11.3.7.5.3.2 Australia: Brain Cancer Diagnostic Market, by Platform and Services, 2019 - 2028 (US$ Million)
11.3.7.5.4 Australia: Brain Cancer Diagnostic Market Revenue and Forecasts to 2028, By Cancer Type (US$ Million)
11.3.7.5.5 Australia: Brain Cancer Diagnostic Market, by Tumor Size - Revenue and Forecast to 2028 (US$ Million)
11.3.7.5.6 Australia: Brain Cancer Diagnostic Market, by End User - Revenue and Forecast to 2028 (US$ Million)
11.3.7.6 Rest of Asia Pacific: Brain Cancer Diagnostic Market - Revenue and Forecast to 2028 (US$ Million)
11.3.7.6.1 Overview
11.3.7.6.2 Rest of Asia Pacific: Brain Cancer Diagnostic Market - Revenue and Forecast to 2028 (US$ Million)
11.3.7.6.3 Rest of Asia Pacific: Brain Cancer Diagnostic Market Revenue and Forecasts to 2028, By Diagnostic Type (US$ Million)
11.3.7.6.3.1 Rest of Asia Pacific: Brain Cancer Diagnostic Market, by Imaging Test, 2019 - 2028 (US$ Million)
11.3.7.6.3.2 Rest of Asia Pacific: Brain Cancer Diagnostic Market, by Platform and Services, 2019 - 2028 (US$ Million)
11.3.7.6.4 Rest of Asia Pacific: Brain Cancer Diagnostic Market Revenue and Forecasts to 2028, By Cancer Type (US$ Million)
11.3.7.6.5 Rest of Asia Pacific: Brain Cancer Diagnostic Market, by Tumor Size - Revenue and Forecast to 2028 (US$ Million)
11.3.7.6.6 Rest of Asia Pacific: Brain Cancer Diagnostic Market, by End User - Revenue and Forecast to 2028 (US$ Million)
11.4 Middle East & Africa Brain Cancer Diagnostics Market Revenue and Forecast To 2028
11.4.1 Overview
11.4.2 Middle East and Africa: Brain Cancer Diagnostics Market - Revenue and Forecast to 2028 (US$ & lsquo;Million)
11.4.3 Middle East and Africa: Brain Cancer Diagnostics, By Diagnostic Type 2019 - 2028 (US$ & lsquo;Million)
11.4.3.1 Middle East and Africa: Brain Cancer Diagnostics, By Imaging Test 2019 - 2028 (US$ & lsquo;Million)
11.4.3.2 Middle East and Africa: Brain Cancer Diagnostics, By Platform and Services 2019 - 2028 (US$ & lsquo;Million)
11.4.4 Middle East and Africa: Brain Cancer Diagnostics Market, By Cancer Type, 2019 - 2028 (US$ & lsquo;Million)
11.4.5 Middle East and Africa: Brain Cancer Diagnostics Market, by End User, 2019 - 2028 (US$ Million)
11.4.6 Middle East and Africa: Brain Cancer Diagnostics Market, by Tumor Size, 2019 - 2028 (US$ Million)
11.4.7 Middle East and Africa: Brain Cancer Diagnostics Market, by Country, 2022 & 2028 (%)
11.4.7.1 UAE: Brain Cancer Diagnostics Market - Revenue and Forecast to 2028 (US$ & lsquo;Million)
11.4.7.1.1 UAE: Brain Cancer Diagnostics Market - Revenue and Forecast to 2028 (US$ & lsquo;Million)
11.4.7.1.2 UAE: Brain Cancer Diagnostics, By Diagnostic Type 2019 - 2028 (US$ & lsquo;Million)
11.4.7.1.2.1 UAE: Brain Cancer Diagnostics, By Platform and Services 2019 - 2028 (US$ & lsquo;Million)
11.4.7.1.2.2 UAE: Brain Cancer Diagnostics, by Imaging Test 2019 - 2028 (US$ & lsquo;Million)
11.4.7.1.3 UAE: Brain Cancer Diagnostics Market, By Cancer Type, 2019 - 2028 (US$ & lsquo;Million)
11.4.7.1.4 UAE: Brain Cancer Diagnostics Market, by End User, 2019 - 2028 (US$ & lsquo;Million)
11.4.7.1.5 UAE: Brain Cancer Diagnostics Market, by Tumor Size, 2019 - 2028 (US$ & lsquo;Million)
11.4.7.2 Saudi Arabia: Brain Cancer Diagnostics Market - Revenue and Forecast to 2028 (US$ & lsquo;Million)
11.4.7.2.1 Saudi Arabia: Brain Cancer Diagnostics Market - Revenue and Forecast to 2028 (US$ & lsquo;Million)
11.4.7.2.2 Saudi Arabia: Brain Cancer Diagnostics Market, By Diagnostic Type, 2019 - 2028 (US$ & lsquo;Million)
11.4.7.2.2.1 Saudi Arabia: Brain Cancer Diagnostics Market, By Imaging Test, 2019 - 2028 (US$ & lsquo;Million)
11.4.7.2.2.2 Saudi Arabia: Brain Cancer Diagnostics Market, By Platform and Services, 2019 - 2028 (US$ & lsquo;Million)
11.4.7.2.3 Saudi Arabia: Brain Cancer Diagnostics Market, By Cancer Type, 2019 - 2028 (US$ & lsquo;Million)
11.4.7.2.4 Saudi Arabia: Brain Cancer Diagnostics Market, by End User, 2019 - 2028 (US$ & lsquo;Million)
11.4.7.2.5 Saudi Arabia: Brain Cancer Diagnostics Market, by Tumor Size, 2019 - 2028 (US$ & lsquo;Million)
11.4.7.3 South Africa: Brain Cancer Diagnostics Market - Revenue and Forecast to 2028 (US$ & lsquo;Million)
11.4.7.3.1 South Africa: Brain Cancer Diagnostics Market - Revenue and Forecast to 2028 (US$ & lsquo;Million)
11.4.7.3.2 South Africa: Brain Cancer Diagnostics Market, By Diagnostic Type, 2019 - 2028 (US$ & lsquo;Million)
11.4.7.3.2.1 South Africa: Brain Cancer Diagnostics Market, by Imaging Test, 2019 - 2028 (US$ & lsquo;Million)
11.4.7.3.2.2 South Africa: Brain Cancer Diagnostics Market, By Platform and Services, 2019 - 2028 (US$ & lsquo;Million)
11.4.7.3.3 South Africa: Brain Cancer Diagnostics Market, By Cancer Type, 2019 - 2028 (US$ & lsquo;Million)
11.4.7.3.4 South Africa: Brain Cancer Diagnostics Market, by End User, 2019 - 2028 (US$ & lsquo;Million)
11.4.7.3.5 South Africa: Brain Cancer Diagnostics Market, by Tumor Size, 2019 - 2028 (US$ & lsquo;Million)
11.4.7.4 Rest of Middle East and Africa: Brain Cancer Diagnostics Market - Revenue and Forecast to 2028 (US$ & lsquo;Million)
11.4.7.4.1 Rest of Middle East and Africa: Brain Cancer Diagnostics Market - Revenue and Forecast to 2028 (US$ & lsquo;Million)
11.4.7.4.2 Rest of Middle East and Africa: Brain Cancer Diagnostics, By Diagnostic Type, 2019 - 2028 (US$ & lsquo;Million)
11.4.7.4.2.1 Rest of Middle East and Africa: Brain Cancer Diagnostics, By Imaging Test, 2019 - 2028 (US$ & lsquo;Million)
11.4.7.4.2.2 Rest of Middle East and Africa: Brain Cancer Diagnostics, By Platform and Services, 2019 - 2028 (US$ & lsquo;Million)
11.4.7.4.3 Rest of Middle East and Africa: Brain Cancer Diagnostics Market, By Cancer Type, 2019 - 2028 (US$ & lsquo;Million)
11.4.7.4.4 Rest of Middle East and Africa: Brain Cancer Diagnostics Market, by End User, 2019 - 2028 (US$ & lsquo;Million)
11.4.7.4.5 Rest of Middle East and Africa: Brain Cancer Diagnostics Market, by Tumor Size, 2019 - 2028 (US$ & lsquo;Million)
11.5 South and Central America Brain Cancer Diagnostics Market Revenue and Forecast To 2028
11.5.1 Overview
11.5.2 South and Central America: Brain Cancer Diagnostics Market - Revenue and Forecast to 2028 (USD Million)
11.5.3 South and Central America Brain Cancer Diagnostics Market, by Diagnostics Type - Revenue and Forecast to 2028 (USD Million)
11.5.3.1 South and Central America Brain Cancer Diagnostics Market, by Imaging Test - Revenue and Forecast to 2028 (USD Million)
11.5.3.2 South and Central America Brain Cancer Diagnostics Market, by Platform and Services - Revenue and Forecast to 2028 (USD Million)
11.5.4 South and Central America Brain Cancer Diagnostics Market, by Cancer Type - Revenue and Forecast to 2028 (USD Million)
11.5.5 South and Central America Brain Cancer Diagnostics Market, by End User - Revenue and Forecast to 2028 (USD Million)
11.5.6 South and Central America Brain Cancer Diagnostics Market, by Tumor Size - Revenue and Forecast to 2028 (USD Million)
11.5.7 South and Central America: Brain Cancer Diagnostics Market, by Country, 2021 & 2028 (%)
11.5.7.1 Brazil: Brain Cancer Diagnostics Market - Revenue and Forecast to 2028 (USD Million)
11.5.7.1.1 Overview
11.5.7.1.2 Brazil: Brain Cancer Diagnostics Market - Revenue and Forecast to 2028 (USD Million)
11.5.7.1.3 Brazil Brain Cancer Diagnostics Market, by Diagnostics Type - Revenue and Forecast to 2028 (USD Million)
11.5.7.1.3.1 Brazil Brain Cancer Diagnostics Market, by Imaging Test - Revenue and Forecast to 2028 (USD Million)
11.5.7.1.3.2 Brazil Brain Cancer Diagnostics Market, by Platform and Services - Revenue and Forecast to 2028 (USD Million)
11.5.7.1.4 Brazil Brain Cancer Diagnostics Market, by Cancer Type - Revenue and Forecast to 2028 (USD Million)
11.5.7.1.5 Brazil Brain Cancer Diagnostics Market, by End User - Revenue and Forecast to 2028 (USD Million)
11.5.7.1.6 Brazil Brain Cancer Diagnostics Market, by Tumor Size - Revenue and Forecast to 2028 (USD Million)
11.5.7.2 Argentina: Brain Cancer Diagnostics Market - Revenue and Forecast to 2028 (USD Million)
11.5.7.2.1 Overview
11.5.7.2.2 Argentina: Brain Cancer Diagnostics Market - Revenue and Forecast to 2028 (USD Million)
11.5.7.2.3 Argentina Brain Cancer Diagnostics Market, by Diagnostics Type - Revenue and Forecast to 2028 (USD Million)
11.5.7.2.3.1 Argentina Brain Cancer Diagnostics Market, by Imaging Test - Revenue and Forecast to 2028 (USD Million)
11.5.7.2.3.2 Argentina Brain Cancer Diagnostics Market, by Platform and Services - Revenue and Forecast to 2028 (USD Million)
11.5.7.2.4 Argentina Brain Cancer Diagnostics Market, by Cancer Type - Revenue and Forecast to 2028 (USD Million)
11.5.7.2.5 Argentina Brain Cancer Diagnostics Market, by End User - Revenue and Forecast to 2028 (USD Million)
11.5.7.2.6 Argentina Brain Cancer Diagnostics Market, by Tumor Size - Revenue and Forecast to 2028 (USD Million)
11.5.7.3 Rest of South and Central America: Brain Cancer Diagnostics Market - Revenue and Forecast to 2028 (USD Million)
11.5.7.3.1 Overview
11.5.7.3.2 Rest of South and Central America: Brain Cancer Diagnostics Market - Revenue and Forecast to 2028 (USD Million)
11.5.7.3.3 Rest of South and Central America Brain Cancer Diagnostics Market, by Diagnostics Type - Revenue and Forecast to 2028 (USD Million)
11.5.7.3.3.1 Rest of South and Central America Brain Cancer Diagnostics Market, by Imaging Test - Revenue and Forecast to 2028 (USD Million)
11.5.7.3.3.2 Rest of South and Central America Brain Cancer
Companies Mentioned
- THERMO FISHER SCIENTIFIC INC
- Siemens Healthineers AG
- GE Healthcare
- MDxHealth
- NantOmics
- Biocept, Inc.
- Koninklijke Philips N.V.
- Canon Medical Systems
- Hitachi, Ltd
- Neusoft Medical Systems
- KITZ HEIDELBERG
- GENPATH
- NVIDIA CORPORATION
- ONCORA MEDICAL
- BIOMIND
- SOPHIA AND ONCODNA
- Clinspec Diagnostics
- Raindance Technologies, Inc
- ROCHE DIAGNOSTICS
- Illumina, Inc.
Table Information
| Report Attribute | Details |
|---|---|
| No. of Pages | 302 |
| Published | June 2022 |
| Forecast Period | 2022 - 2028 |
| Estimated Market Value ( USD | $ 1639.1 Million |
| Forecasted Market Value ( USD | $ 7378.57 Million |
| Compound Annual Growth Rate | 28.5% |
| Regions Covered | Global |
| No. of Companies Mentioned | 20 |
